1 Report Overview 1.1 GABA (CAS 56-12-2) Research Scope 1.2 Market Segment by Type 1.2.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Production Process 1.2.2 Biological Fermentation 1.2.3 Chemical Synthesis 1.3 Market Segment by Application 1.3.1 Global GABA (CAS 56-12-2) Market Size Growth Rate by Application 1.3.2 Pharmaceuticals & Food 1.3.3 Animal Feeds 1.3.4 Plants Growth Promoter 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Market Production 2.1 Global GABA (CAS 56-12-2) Production Capacity (2016-2027) 2.2 Global GABA (CAS 56-12-2) Production by Region: 2016 VS 2021 VS 2027 2.3 Global GABA (CAS 56-12-2) Production by Region 2.3.1 Global GABA (CAS 56-12-2) Historic Production by Region (2016-2021) 2.3.2 Global GABA (CAS 56-12-2) Forecasted Production by Region (2022-2027) 2.3.3 North America 2.3.4 Europe 2.3.5 Japan 2.36 China 2.3.7 South Korea 2.3.8 India 2.4 Industry Trends 2.4.1 GABA (CAS 56-12-2) Industry Trends 2.4.2 GABA (CAS 56-12-2) Market Drivers 2.4.3 GABA (CAS 56-12-2) Market Challenges 2.4.4 GABA (CAS 56-12-2) Market Restraints 3 Global GABA (CAS 56-12-2) Sales 3.1 Global GABA (CAS 56-12-2) Sales Estimates and Forecasts 2016-2027 3.2 Global GABA (CAS 56-12-2) Revenue Estimates and Forecasts 2016-2027 3.3 Global GABA (CAS 56-12-2) Revenue by Region: 2016 VS 2021 VS 2027 3.4 Global Top GABA (CAS 56-12-2) Regions by Sales 3.4.1 Global Top GABA (CAS 56-12-2) Regions by Sales (2016-2021) 3.4.2 Global Top GABA (CAS 56-12-2) Regions by Sales (2022-2027) 3.5 Global Top GABA (CAS 56-12-2) Regions by Revenue 3.5.1 Global Top GABA (CAS 56-12-2) Regions by Revenue (2016-2021) 3.5.2 Global Top GABA (CAS 56-12-2) Regions by Revenue (2022-2027) 3.5.3 North America 3.5.4 Europe 3.5.5 Asia-Pacific 3.5.6 Latin America 3.5.7 Middle East & Africa 4 Competition by Manufacturers 4.1 Global GABA (CAS 56-12-2) Production Capacity by Manufacturers 4.2 Global GABA (CAS 56-12-2) Sales by Manufacturers 4.2.1 Global Top GABA (CAS 56-12-2) Manufacturers by Sales (2016-2021) 4.2.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Sales (2016-2021) 4.2.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Sales in 2020 4.3 Global GABA (CAS 56-12-2) Revenue by Manufacturers 4.3.1 Global Top GABA (CAS 56-12-2) Manufacturers by Revenue (2016-2021) 4.3.2 Global Top GABA (CAS 56-12-2) Manufacturers Market Share by Revenue (2016-2021) 4.3.3 Global Top 10 and Top 5 Companies by GABA (CAS 56-12-2) Revenue in 2020 4.4 Global GABA (CAS 56-12-2) Sales Price by Manufacturers 4.5 Analysis of Competitive Landscape 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 4.5.2 Global GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.5.3 Global GABA (CAS 56-12-2) Manufacturers Geographical Distribution 4.6 Mergers & Acquisitions, Expansion Plans 5 Estimates and Forecasts by Production Process 5.1 Global GABA (CAS 56-12-2) Sales by Production Process 5.1.1 Global GABA (CAS 56-12-2) Historical Sales by Production Process (2016-2021) 5.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Production Process (2022-2027) 5.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) 5.2 Global GABA (CAS 56-12-2) Revenue by Production Process 5.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Production Process (2016-2021) 5.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Production Process (2022-2027) 5.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) 5.3 Global GABA (CAS 56-12-2) Price by Production Process 5.3.1 Global GABA (CAS 56-12-2) Price by Production Process (2016-2021) 5.3.2 Global GABA (CAS 56-12-2) Price Forecast by Production Process (2022-2027) 6 Market Size by Application 6.1 Global GABA (CAS 56-12-2) Sales by Application 6.1.1 Global GABA (CAS 56-12-2) Historical Sales by Application (2016-2021) 6.1.2 Global GABA (CAS 56-12-2) Forecasted Sales by Application (2022-2027) 6.1.3 Global GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) 6.2 Global GABA (CAS 56-12-2) Revenue by Application 6.2.1 Global GABA (CAS 56-12-2) Historical Revenue by Application (2016-2021) 6.2.2 Global GABA (CAS 56-12-2) Forecasted Revenue by Application (2022-2027) 6.2.3 Global GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) 6.3 Global GABA (CAS 56-12-2) Price by Application 6.3.1 Global GABA (CAS 56-12-2) Price by Application (2016-2021) 6.3.2 Global GABA (CAS 56-12-2) Price Forecast by Application (2022-2027) 7 North America 7.1 North America GABA (CAS 56-12-2) Sales Breakdown by Company 7.1.1 North America GABA (CAS 56-12-2) Sales by Company (2016-2021) 7.1.2 North America GABA (CAS 56-12-2) Revenue by Company (2016-2021) 7.2 North America GABA (CAS 56-12-2) Market Size by Production Process 7.2.1 North America GABA (CAS 56-12-2) Sales by Production Process (2016-2027) 7.2.2 North America GABA (CAS 56-12-2) Revenue by Production Process (2016-2027) 7.3 North America GABA (CAS 56-12-2) Market Size by Application 7.3.1 North America GABA (CAS 56-12-2) Sales by Application (2016-2027) 7.3.2 North America GABA (CAS 56-12-2) Revenue by Application (2016-2027) 7.4 North America GABA (CAS 56-12-2) Market Size by Country 7.4.1 North America GABA (CAS 56-12-2) Sales by Country (2016-2027) 7.4.2 North America GABA (CAS 56-12-2) Revenue by Country (2016-2027) 7.4.3 U.S. 7.4.4 Canada 8 Europe 8.1 Europe GABA (CAS 56-12-2) Sales Breakdown by Company 8.1.1 Europe GABA (CAS 56-12-2) Sales by Company (2016-2021) 8.1.2 Europe GABA (CAS 56-12-2) Revenue by Company (2016-2021) 8.2 Europe GABA (CAS 56-12-2) Market Size by Production Process 8.2.1 Europe GABA (CAS 56-12-2) Sales by Production Process (2016-2028) 8.2.2 Europe GABA (CAS 56-12-2) Revenue by Production Process (2016-2028) 8.3 Europe GABA (CAS 56-12-2) Market Size by Application 8.3.1 Europe GABA (CAS 56-12-2) Sales by Application (2016-2028) 8.3.2 Europe GABA (CAS 56-12-2) Revenue by Application (2016-2028) 8.4 Europe GABA (CAS 56-12-2) Market Size by Country 8.4.1 Europe GABA (CAS 56-12-2) Sales by Country (2016-2028) 8.4.2 Europe GABA (CAS 56-12-2) Revenue by Country (2016-2028) 8.4.3 Germany 8.4.4 France 8.4.5 U.K. 8.4.6 Italy 8.4.7 Russia 9 Asia Pacific 9.1 Asia Pacific GABA (CAS 56-12-2) Sales Breakdown by Company 9.1.1 Asia Pacific GABA (CAS 56-12-2) Sales by Company (2016-2021) 9.1.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Company (2016-2021) 9.2 Asia Pacific GABA (CAS 56-12-2) Market Size by Production Process 9.2.1 Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2016-2029) 9.2.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2016-2029) 9.3 Asia Pacific GABA (CAS 56-12-2) Market Size by Application 9.3.1 Asia Pacific GABA (CAS 56-12-2) Sales by Application (2016-2029) 9.3.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2016-2029) 9.4 Asia Pacific GABA (CAS 56-12-2) Market Size by Region 9.4.1 Asia Pacific GABA (CAS 56-12-2) Sales by Region (2016-2029) 9.4.2 Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2016-2029) 9.4.3 China 9.4.4 Japan 9.4.5 South Korea 9.4.6 India 9.4.7 Australia 9.4.8 China Taiwan 9.4.9 Indonesia 9.4.10 Thailand 9.4.11 Malaysia 10 Latin America 10.1 Latin America GABA (CAS 56-12-2) Sales Breakdown by Company 10.1.1 Latin America GABA (CAS 56-12-2) Sales by Company (2016-2021) 10.1.2 Latin America GABA (CAS 56-12-2) Revenue by Company (2016-2021) 10.2 Latin America GABA (CAS 56-12-2) Market Size by Production Process 10.2.1 Latin America GABA (CAS 56-12-2) Sales by Production Process (2016-20210) 10.2.2 Latin America GABA (CAS 56-12-2) Revenue by Production Process (2016-20210) 10.3 Latin America GABA (CAS 56-12-2) Market Size by Application 10.3.1 Latin America GABA (CAS 56-12-2) Sales by Application (2016-20210) 10.3.2 Latin America GABA (CAS 56-12-2) Revenue by Application (2016-20210) 10.4 Latin America GABA (CAS 56-12-2) Market Size by Country 10.4.1 Latin America GABA (CAS 56-12-2) Sales by Country (2016-20210) 10.4.2 Latin America GABA (CAS 56-12-2) Revenue by Country (2016-20210) 10.4.3 Mexico 10.4.4 Brazil 10.4.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa GABA (CAS 56-12-2) Sales Breakdown by Company 11.1.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Company (2016-2021) 11.1.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Company (2016-2021) 11.2 Middle East and Africa GABA (CAS 56-12-2) Market Size by Production Process 11.2.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2016-20211) 11.2.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2016-20211) 11.3 Middle East and Africa GABA (CAS 56-12-2) Market Size by Application 11.3.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2016-20211) 11.3.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2016-20211) 11.4 Middle East and Africa GABA (CAS 56-12-2) Market Size by Country 11.4.1 Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2016-20211) 11.4.2 Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2016-20211) 11.4.3 Turkey 11.4.4 Saudi Arabia 11.4.5 UAE 12 Company Profiles 12.1 Pharma Foods International 12.1.1 Pharma Foods International Corporation Information 12.1.2 Pharma Foods International Overview 12.1.3 Pharma Foods International GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.1.4 Pharma Foods International GABA (CAS 56-12-2) Products and Services 12.1.5 Pharma Foods International GABA (CAS 56-12-2) SWOT Analysis 12.1.6 Pharma Foods International Recent Developments 12.2 Kyowa Hakko 12.2.1 Kyowa Hakko Corporation Information 12.2.2 Kyowa Hakko Overview 12.2.3 Kyowa Hakko GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.2.4 Kyowa Hakko GABA (CAS 56-12-2) Products and Services 12.2.5 Kyowa Hakko GABA (CAS 56-12-2) SWOT Analysis 12.2.6 Kyowa Hakko Recent Developments 12.3 Sekisui Chemical 12.3.1 Sekisui Chemical Corporation Information 12.3.2 Sekisui Chemical Overview 12.3.3 Sekisui Chemical GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.3.4 Sekisui Chemical GABA (CAS 56-12-2) Products and Services 12.3.5 Sekisui Chemical GABA (CAS 56-12-2) SWOT Analysis 12.3.6 Sekisui Chemical Recent Developments 12.4 Zhejiang YiWan Biolabs 12.4.1 Zhejiang YiWan Biolabs Corporation Information 12.4.2 Zhejiang YiWan Biolabs Overview 12.4.3 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.4.4 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Products and Services 12.4.5 Zhejiang YiWan Biolabs GABA (CAS 56-12-2) SWOT Analysis 12.4.6 Zhejiang YiWan Biolabs Recent Developments 12.5 Shanghai Richen 12.5.1 Shanghai Richen Corporation Information 12.5.2 Shanghai Richen Overview 12.5.3 Shanghai Richen GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.5.4 Shanghai Richen GABA (CAS 56-12-2) Products and Services 12.5.5 Shanghai Richen GABA (CAS 56-12-2) SWOT Analysis 12.5.6 Shanghai Richen Recent Developments 12.6 Guangdong Luckerkong Biotech 12.6.1 Guangdong Luckerkong Biotech Corporation Information 12.6.2 Guangdong Luckerkong Biotech Overview 12.6.3 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.6.4 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Products and Services 12.6.5 Guangdong Luckerkong Biotech GABA (CAS 56-12-2) SWOT Analysis 12.6.6 Guangdong Luckerkong Biotech Recent Developments 12.7 Tianjin Shijitianlong Biotech 12.7.1 Tianjin Shijitianlong Biotech Corporation Information 12.7.2 Tianjin Shijitianlong Biotech Overview 12.7.3 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.7.4 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Products and Services 12.7.5 Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) SWOT Analysis 12.7.6 Tianjin Shijitianlong Biotech Recent Developments 12.8 Ningxiang Jiayuan Biology Technology 12.8.1 Ningxiang Jiayuan Biology Technology Corporation Information 12.8.2 Ningxiang Jiayuan Biology Technology Overview 12.8.3 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.8.4 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Products and Services 12.8.5 Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) SWOT Analysis 12.8.6 Ningxiang Jiayuan Biology Technology Recent Developments 12.9 Zhejiang Tianrui Chemical 12.9.1 Zhejiang Tianrui Chemical Corporation Information 12.9.2 Zhejiang Tianrui Chemical Overview 12.9.3 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.9.4 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Products and Services 12.9.5 Zhejiang Tianrui Chemical GABA (CAS 56-12-2) SWOT Analysis 12.9.6 Zhejiang Tianrui Chemical Recent Developments 12.10 Taizhou Xinyou Pharmaceutical & Chemical 12.10.1 Taizhou Xinyou Pharmaceutical & Chemical Corporation Information 12.10.2 Taizhou Xinyou Pharmaceutical & Chemical Overview 12.10.3 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.10.4 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Products and Services 12.10.5 Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) SWOT Analysis 12.10.6 Taizhou Xinyou Pharmaceutical & Chemical Recent Developments 12.11 Bloomage Biotechnology Corporation Limited 12.11.1 Bloomage Biotechnology Corporation Limited Corporation Information 12.11.2 Bloomage Biotechnology Corporation Limited Overview 12.11.3 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.11.4 Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Products and Services 12.11.5 Bloomage Biotechnology Corporation Limited Recent Developments 12.12 Bornsun Bioengineering 12.12.1 Bornsun Bioengineering Corporation Information 12.12.2 Bornsun Bioengineering Overview 12.12.3 Bornsun Bioengineering GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.12.4 Bornsun Bioengineering GABA (CAS 56-12-2) Products and Services 12.12.5 Bornsun Bioengineering Recent Developments 12.13 Luoyang Huarong 12.13.1 Luoyang Huarong Corporation Information 12.13.2 Luoyang Huarong Overview 12.13.3 Luoyang Huarong GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.13.4 Luoyang Huarong GABA (CAS 56-12-2) Products and Services 12.13.5 Luoyang Huarong Recent Developments 12.14 Anhui Xinnuobei 12.14.1 Anhui Xinnuobei Corporation Information 12.14.2 Anhui Xinnuobei Overview 12.14.3 Anhui Xinnuobei GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.14.4 Anhui Xinnuobei GABA (CAS 56-12-2) Products and Services 12.14.5 Anhui Xinnuobei Recent Developments 12.15 Hefei Maikeluo Biological Engineering 12.15.1 Hefei Maikeluo Biological Engineering Corporation Information 12.15.2 Hefei Maikeluo Biological Engineering Overview 12.15.3 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.15.4 Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Products and Services 12.15.5 Hefei Maikeluo Biological Engineering Recent Developments 12.16 Hangzhou Viablife Biotech 12.16.1 Hangzhou Viablife Biotech Corporation Information 12.16.2 Hangzhou Viablife Biotech Overview 12.16.3 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.16.4 Hangzhou Viablife Biotech GABA (CAS 56-12-2) Products and Services 12.16.5 Hangzhou Viablife Biotech Recent Developments 12.17 Guangxi Hanhe Biotech 12.17.1 Guangxi Hanhe Biotech Corporation Information 12.17.2 Guangxi Hanhe Biotech Overview 12.17.3 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales, Revenue, Price and Gross Margin (2016-2021) 12.17.4 Guangxi Hanhe Biotech GABA (CAS 56-12-2) Products and Services 12.17.5 Guangxi Hanhe Biotech Recent Developments 13 Value Chain and Sales Channels Analysis 13.1 GABA (CAS 56-12-2) Value Chain Analysis 13.2 GABA (CAS 56-12-2) Key Raw Materials 13.2.1 Key Raw Materials 13.2.2 Raw Materials Key Suppliers 13.3 GABA (CAS 56-12-2) Production Mode & Process 13.4 GABA (CAS 56-12-2) Sales and Marketing 13.4.1 GABA (CAS 56-12-2) Sales Channels 13.4.2 GABA (CAS 56-12-2) Distributors 13.5 GABA (CAS 56-12-2) Customers 14 Key Findings 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global GABA (CAS 56-12-2) Market Size Growth Rate by Production Process: 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Biological Fermentation Table 3. Major Manufacturers of Chemical Synthesis Table 4. Global GABA (CAS 56-12-2) Market Size Growth Rate by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 5. Global GABA (CAS 56-12-2) Production by Region: 2016 VS 2021 VS 2027 (MT) Table 6. Global GABA (CAS 56-12-2) Production by Region (2016-2021) & (MT) Table 7. Global GABA (CAS 56-12-2) Production Market Share by Region (2016-2021) Table 8. Global GABA (CAS 56-12-2) Production by Region (2022-2027) & (MT) Table 9. Global GABA (CAS 56-12-2) Production Market Share by Region (2022-2027) Table 10. GABA (CAS 56-12-2) Market Trends Table 11. GABA (CAS 56-12-2) Market Drivers Table 12. GABA (CAS 56-12-2) Market Challenges Table 13. GABA (CAS 56-12-2) Market Restraints Table 14. Global GABA (CAS 56-12-2) Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 15. Global GABA (CAS 56-12-2) Sales by Region (2016-2021) & (MT) Table 16. Global GABA (CAS 56-12-2) Sales Market Share by Region (2016-2021) Table 17. Global GABA (CAS 56-12-2) Sales by Region (2022-2027) & (MT) Table 18. Global GABA (CAS 56-12-2) Sales Market Share by Region (2022-2027) Table 19. Global GABA (CAS 56-12-2) Revenue by Region (2016-2021) & (US$ Million) Table 20. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2016-2021) Table 21. Global GABA (CAS 56-12-2) Revenue by Region (2022-2027) & (US$ Million) Table 22. Global GABA (CAS 56-12-2) Revenue Market Share by Region (2022-2027) Table 23. Global GABA (CAS 56-12-2) Production Capacity by Manufacturers (2016-2021) & (MT) Table 24. Global GABA (CAS 56-12-2) Capacity Market Share by Manufacturers (2016-2021) Table 25. Global GABA (CAS 56-12-2) Production by Manufacturers (2016-2021) & (MT) Table 26. Global GABA (CAS 56-12-2) Production Market Share by Manufacturers (2016-2021) Table 27. Global GABA (CAS 56-12-2) Sales by Manufacturers (2016-2021) & (MT) Table 28. Global GABA (CAS 56-12-2) Sales Share by Manufacturers (2016-2021) Table 29. Global GABA (CAS 56-12-2) Revenue by Manufacturers (2016-2021) & (US$ Million) Table 30. Global GABA (CAS 56-12-2) Revenue Share by Manufacturers (2016-2021) Table 31. GABA (CAS 56-12-2) Price by Manufacturers 2016-2021 (USD/MT) Table 32. Global GABA (CAS 56-12-2) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global GABA (CAS 56-12-2) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in GABA (CAS 56-12-2) as of 2020) Table 34. GABA (CAS 56-12-2) Manufacturing Base Distribution and Headquarters Table 35. Manufacturers GABA (CAS 56-12-2) Product Offered Table 36. Date of Key Manufacturers Enter into GABA (CAS 56-12-2) Market Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 39. Global GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 40. Global GABA (CAS 56-12-2) Sales Share by Production Process (2016-2021) Table 41. Global GABA (CAS 56-12-2) Sales Share by Production Process (2022-2027) Table 42. Global GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 43. Global GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 44. Global GABA (CAS 56-12-2) Revenue Share by Production Process (2016-2021) Table 45. Global GABA (CAS 56-12-2) Revenue Share by Production Process (2022-2027) Table 46. GABA (CAS 56-12-2) Price by Production Process (2016-2021) & (USD/MT) Table 47. Global GABA (CAS 56-12-2) Price Forecast by Production Process (2022-2027) & (USD/MT) Table 48. Global GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 49. Global GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 50. Global GABA (CAS 56-12-2) Sales Share by Application (2016-2021) Table 51. Global GABA (CAS 56-12-2) Sales Share by Application (2022-2027) Table 52. Global GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 53. Global GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 54. Global GABA (CAS 56-12-2) Revenue Share by Application (2016-2021) Table 55. Global GABA (CAS 56-12-2) Revenue Share by Application (2022-2027) Table 56. GABA (CAS 56-12-2) Price by Application (2016-2021) & (USD/MT) Table 57. Global GABA (CAS 56-12-2) Price Forecast by Application (2022-2027) & (USD/MT) Table 58. North America GABA (CAS 56-12-2) Sales by Company (2016-2021) & (MT) Table 59. North America GABA (CAS 56-12-2) Sales Market Share by Company (2016-2021) Table 60. North America GABA (CAS 56-12-2) Revenue by Company (2016-2021) & (US$ Million) Table 61. North America GABA (CAS 56-12-2) Revenue Market Share by Company (2016-2021) Table 62. North America GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 63. North America GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 64. North America GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 65. North America GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 66. North America GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 67. North America GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 68. North America GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 69. North America GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 70. North America GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT) Table 71. North America GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT) Table 72. North America GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million) Table 73. North America GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million) Table 74. Europe GABA (CAS 56-12-2) Sales by Company (2016-2021) & (MT) Table 75. Europe GABA (CAS 56-12-2) Sales Market Share by Company (2016-2021) Table 76. Europe GABA (CAS 56-12-2) Revenue by Company (2016-2021) & (US$ Million) Table 77. Europe GABA (CAS 56-12-2) Revenue Market Share by Company (2016-2021) Table 78. Europe GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 79. Europe GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 80. Europe GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 81. Europe GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 82. Europe GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 83. Europe GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 84. Europe GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 85. Europe GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 86. Europe GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT) Table 87. Europe GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT) Table 88. Europe GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million) Table 89. Europe GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million) Table 90. Asia Pacific GABA (CAS 56-12-2) Sales by Company (2016-2021) & (MT) Table 91. Asia Pacific GABA (CAS 56-12-2) Sales Market Share by Company (2016-2021) Table 92. Asia Pacific GABA (CAS 56-12-2) Revenue by Company (2016-2021) & (US$ Million) Table 93. Asia Pacific GABA (CAS 56-12-2) Revenue Market Share by Company (2016-2021) Table 94. Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 95. Asia Pacific GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 96. Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 97. Asia Pacific GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 98. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 99. Asia Pacific GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 100. Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 101. Asia Pacific GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 102. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2016-2021) & (MT) Table 103. Asia Pacific GABA (CAS 56-12-2) Sales by Region (2022-2027) & (MT) Table 104. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2016-2021) & (US$ Million) Table 105. Asia Pacific GABA (CAS 56-12-2) Revenue by Region (2022-2027) & (US$ Million) Table 106. Latin America GABA (CAS 56-12-2) Sales by Company (2016-2021) & (MT) Table 107. Latin America GABA (CAS 56-12-2) Sales Market Share by Company (2016-2021) Table 108. Latin America GABA (CAS 56-12-2) Revenue by Company (2016-2021) & (US$ Million) Table 109. Latin America GABA (CAS 56-12-2) Revenue Market Share by Company (2016-2021) Table 110. Latin America GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 111. Latin America GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 112. Latin America GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 113. Latin America GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 114. Latin America GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 115. Latin America GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 116. Latin America GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 117. Latin America GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 118. Latin America GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT) Table 119. Latin America GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT) Table 120. Latin America GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million) Table 121. Latin America GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million) Table 122. Middle East and Africa GABA (CAS 56-12-2) Sales by Company (2016-2021) & (MT) Table 123. Middle East and Africa GABA (CAS 56-12-2) Sales Market Share by Company (2016-2021) Table 124. Middle East and Africa GABA (CAS 56-12-2) Revenue by Company (2016-2021) & (US$ Million) Table 125. Middle East and Africa GABA (CAS 56-12-2) Revenue Market Share by Company (2016-2021) Table 126. Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2016-2021) & (MT) Table 127. Middle East and Africa GABA (CAS 56-12-2) Sales by Production Process (2022-2027) & (MT) Table 128. Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2016-2021) & (US$ Million) Table 129. Middle East and Africa GABA (CAS 56-12-2) Revenue by Production Process (2022-2027) & (US$ Million) Table 130. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2016-2021) & (MT) Table 131. Middle East and Africa GABA (CAS 56-12-2) Sales by Application (2022-2027) & (MT) Table 132. Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2016-2021) & (US$ Million) Table 133. Middle East and Africa GABA (CAS 56-12-2) Revenue by Application (2022-2027) & (US$ Million) Table 134. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2016-2021) & (MT) Table 135. Middle East and Africa GABA (CAS 56-12-2) Sales by Country (2022-2027) & (MT) Table 136. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2016-2021) & (US$ Million) Table 137. Middle East and Africa GABA (CAS 56-12-2) Revenue by Country (2022-2027) & (US$ Million) Table 138. Pharma Foods International Corporation Information Table 139. Pharma Foods International Description and Overview Table 140. Pharma Foods International GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 141. Pharma Foods International GABA (CAS 56-12-2) Products and Services Table 142. Pharma Foods International GABA (CAS 56-12-2) SWOT Analysis Table 143. Pharma Foods International Recent Development Table 144. Kyowa Hakko Corporation Information Table 145. Kyowa Hakko Description and Overview Table 146. Kyowa Hakko GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 147. Kyowa Hakko GABA (CAS 56-12-2) Products and Services Table 148. Kyowa Hakko GABA (CAS 56-12-2) SWOT Analysis Table 149. Kyowa Hakko Recent Development Table 150. Sekisui Chemical Corporation Information Table 151. Sekisui Chemical Description and Overview Table 152. Sekisui Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 153. Sekisui Chemical GABA (CAS 56-12-2) Products and Services Table 154. Sekisui Chemical GABA (CAS 56-12-2) SWOT Analysis Table 155. Sekisui Chemical Recent Development Table 156. Zhejiang YiWan Biolabs Corporation Information Table 157. Zhejiang YiWan Biolabs Description and Overview Table 158. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 159. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) Products and Services Table 160. Zhejiang YiWan Biolabs GABA (CAS 56-12-2) SWOT Analysis Table 161. Zhejiang YiWan Biolabs Recent Development Table 162. Shanghai Richen Corporation Information Table 163. Shanghai Richen Description and Overview Table 164. Shanghai Richen GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 165. Shanghai Richen GABA (CAS 56-12-2) Products and Services Table 166. Shanghai Richen GABA (CAS 56-12-2) SWOT Analysis Table 167. Shanghai Richen Recent Development Table 168. Guangdong Luckerkong Biotech Corporation Information Table 169. Guangdong Luckerkong Biotech Description and Overview Table 170. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 171. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) Products and Services Table 172. Guangdong Luckerkong Biotech GABA (CAS 56-12-2) SWOT Analysis Table 173. Guangdong Luckerkong Biotech Recent Development Table 174. Tianjin Shijitianlong Biotech Corporation Information Table 175. Tianjin Shijitianlong Biotech Description and Overview Table 176. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 177. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) Products and Services Table 178. Tianjin Shijitianlong Biotech GABA (CAS 56-12-2) SWOT Analysis Table 179. Tianjin Shijitianlong Biotech Recent Development Table 180. Ningxiang Jiayuan Biology Technology Corporation Information Table 181. Ningxiang Jiayuan Biology Technology Description and Overview Table 182. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 183. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) Products and Services Table 184. Ningxiang Jiayuan Biology Technology GABA (CAS 56-12-2) SWOT Analysis Table 185. Ningxiang Jiayuan Biology Technology Recent Development Table 186. Zhejiang Tianrui Chemical Corporation Information Table 187. Zhejiang Tianrui Chemical Description and Overview Table 188. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 189. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) Products and Services Table 190. Zhejiang Tianrui Chemical GABA (CAS 56-12-2) SWOT Analysis Table 191. Zhejiang Tianrui Chemical Recent Development Table 192. Taizhou Xinyou Pharmaceutical & Chemical Corporation Information Table 193. Taizhou Xinyou Pharmaceutical & Chemical Description and Overview Table 194. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 195. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) Products and Services Table 196. Taizhou Xinyou Pharmaceutical & Chemical GABA (CAS 56-12-2) SWOT Analysis Table 197. Taizhou Xinyou Pharmaceutical & Chemical Recent Development Table 198. Bloomage Biotechnology Corporation Limited Corporation Information Table 199. Bloomage Biotechnology Corporation Limited Description and Overview Table 200. Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 201. Bloomage Biotechnology Corporation Limited GABA (CAS 56-12-2) Products and Services Table 202. Bloomage Biotechnology Corporation Limited Recent Development Table 203. Bornsun Bioengineering Corporation Information Table 204. Bornsun Bioengineering Description and Overview Table 205. Bornsun Bioengineering GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 206. Bornsun Bioengineering GABA (CAS 56-12-2) Products and Services Table 207. Bornsun Bioengineering Recent Development Table 208. Luoyang Huarong Corporation Information Table 209. Luoyang Huarong Description and Overview Table 210. Luoyang Huarong GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 211. Luoyang Huarong GABA (CAS 56-12-2) Products and Services Table 212. Luoyang Huarong Recent Development Table 213. Anhui Xinnuobei Corporation Information Table 214. Anhui Xinnuobei Description and Overview Table 215. Anhui Xinnuobei GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 216. Anhui Xinnuobei GABA (CAS 56-12-2) Products and Services Table 217. Anhui Xinnuobei Recent Development Table 218. Hefei Maikeluo Biological Engineering Corporation Information Table 219. Hefei Maikeluo Biological Engineering Description and Overview Table 220. Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 221. Hefei Maikeluo Biological Engineering GABA (CAS 56-12-2) Products and Services Table 222. Hefei Maikeluo Biological Engineering Recent Development Table 223. Hangzhou Viablife Biotech Corporation Information Table 224. Hangzhou Viablife Biotech Description and Overview Table 225. Hangzhou Viablife Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 226. Hangzhou Viablife Biotech GABA (CAS 56-12-2) Products and Services Table 227. Hangzhou Viablife Biotech Recent Development Table 228. Guangxi Hanhe Biotech Corporation Information Table 229. Guangxi Hanhe Biotech Description and Overview Table 230. Guangxi Hanhe Biotech GABA (CAS 56-12-2) Sales (MT), Revenue (US$ Million), Average Selling Price (ASP) & (USD/MT) and Gross Margin (2016-2021) Table 231. Guangxi Hanhe Biotech GABA (CAS 56-12-2) Products and Services Table 232. Guangxi Hanhe Biotech Recent Development Table 233. Key Raw Materials Lists Table 234. Raw Materials Key Suppliers Lists Table 235. GABA (CAS 56-12-2) Distributors List Table 236. GABA (CAS 56-12-2) Customers List Table 237. Research Programs/Design for This Report Table 238. Key Data Information from Secondary Sources Table 239. Key Data Information from Primary Sources List of Figures Figure 1. GABA (CAS 56-12-2) Product Picture Figure 2. Global GABA (CAS 56-12-2) Market Share by Production Process in 2020 & 2027 Figure 3. Biological Fermentation Product Picture Figure 4. Chemical Synthesis Product Picture Figure 5. Global GABA (CAS 56-12-2) Market Share by Application in 2020 & 2027 Figure 6. Pharmaceuticals & Food Figure 7. Animal Feeds Figure 8. Plants Growth Promoter Figure 9. Others Figure 10. Global GABA (CAS 56-12-2) Capacity, Production and Utilization (2016-2027) & (MT) Figure 11. Global GABA (CAS 56-12-2) Production Market Share by Region in Percentage: 2020 Versus 2027 Figure 12. Global GABA (CAS 56-12-2) Production Market Share by Region (2016-2021) Figure 13. Global GABA (CAS 56-12-2) Production Market Share by Region (2022-2027) Figure 14. GABA (CAS 56-12-2) Production Growth Rate in North America (2016-2027) & (MT) Figure 15. GABA (CAS 56-12-2) Production Growth Rate in Europe (2016-2027) & (MT) Figure 16. GABA (CAS 56-12-2) Production Growth Rate in Japan (2016-2027) & (MT) Figure 17. GABA (CAS 56-12-2) Production Growth Rate in China (2016-2027) & (MT) Figure 18. GABA (CAS 56-12-2) Production Growth Rate in South Korea (2016-2027) & (MT) Figure 19. GABA (CAS 56-12-2) Production Growth Rate in India (2016-2027) & (MT) Figure 20. Global GABA (CAS 56-12-2) Sales 2016-2027 (MT) Figure 21. Global GABA (CAS 56-12-2) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 22. Global GABA (CAS 56-12-2) Revenue 2016-2027 (US$ Million) Figure 23. Global GABA (CAS 56-12-2) Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 24. Global GABA (CAS 56-12-2) Sales Market Share by Region (2016-2021) Figure 25. Global GABA (CAS 56-12-2) Sales Market Share by Region (2022-2027) Figure 26. North America GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT) Figure 27. North America GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million) Figure 28. Europe GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT) Figure 29. Europe GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million) Figure 30. Asia-Pacific GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT) Figure 31. Asia-Pacific GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million) Figure 32. Latin America GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT) Figure 33. Latin America GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million) Figure 34. Middle East & Africa GABA (CAS 56-12-2) Sales YoY (2016-2027) & (MT) Figure 35. Middle East & Africa GABA (CAS 56-12-2) Revenue YoY (2016-2027) & (US$ Million) Figure 36. The Top 10 and Top 5 Players Market Share by GABA (CAS 56-12-2) Sales in 2020 Figure 37. The Top 10 and Top 5 Players Market Share by GABA (CAS 56-12-2) Revenue in 2020 Figure 38. GABA (CAS 56-12-2) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 39. Global GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 40. Global GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 41. Global GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 42. Global GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 43. North America GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 44. North America GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 45. North America GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 46. North America GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 47. North America GABA (CAS 56-12-2) Sales Share by Country (2016-2027) Figure 48. North America GABA (CAS 56-12-2) Revenue Share by Country (2016-2027) Figure 49. U.S. GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 50. Canada GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 51. Europe GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 52. Europe GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 53. Europe GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 54. Europe GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 55. Europe GABA (CAS 56-12-2) Sales Share by Country (2016-2027) Figure 56. Europe GABA (CAS 56-12-2) Revenue Share by Country (2016-2027) Figure 57. Germany GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 58. France GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 59. U.K. GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 60. Italy GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 61. Russia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 62. Asia-Pacific GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 63. Asia-Pacific GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 64. Asia-Pacific GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 65. Asia-Pacific GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 66. Asia-Pacific GABA (CAS 56-12-2) Sales Share by Region (2016-2027) Figure 67. Asia-Pacific GABA (CAS 56-12-2) Revenue Share by Region (2016-2027) Figure 68. China GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 69. Japan GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 70. South Korea GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 71. India GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 72. Australia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 73. China Taiwan GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 74. Indonesia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 75. Thailand GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 76. Malaysia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 77. Latin America GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 78. Latin America GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 79. Latin America GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 80. Latin America GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 81. Latin America GABA (CAS 56-12-2) Sales Share by Country (2016-2027) Figure 82. Latin America GABA (CAS 56-12-2) Revenue Share by Country (2016-2027) Figure 83. Mexico GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 84. Brazil GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 85. Argentina GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 86. Middle East & Africa GABA (CAS 56-12-2) Sales Market Share by Production Process (2016-2027) Figure 87. Middle East & Africa GABA (CAS 56-12-2) Revenue Market Share by Production Process (2016-2027) Figure 88. Middle East & Africa GABA (CAS 56-12-2) Sales Market Share by Application (2016-2027) Figure 89. Middle East & Africa GABA (CAS 56-12-2) Revenue Market Share by Application (2016-2027) Figure 90. Middle East & Africa GABA (CAS 56-12-2) Sales Share by Country (2016-2027) Figure 91. Middle East & Africa GABA (CAS 56-12-2) Revenue Share by Country (2016-2027) Figure 92. Turkey GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 93. Saudi Arabia GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 94. UAE GABA (CAS 56-12-2) Revenue (2016-2027) & (US$ Million) Figure 95. GABA (CAS 56-12-2) Value Chain Figure 96. Channels of Distribution Figure 97. Distributors Profiles Figure 98. Bottom-up and Top-down Approaches for This Report Figure 99. Data Triangulation Figure 100. Key Executives Interviewed

Pharma Foods International Kyowa Hakko Sekisui Chemical Zhejiang YiWan Biolabs Shanghai Richen Guangdong Luckerkong Biotech Tianjin Shijitianlong Biotech Ningxiang Jiayuan Biology Technology Zhejiang Tianrui Chemical Taizhou Xinyou Pharmaceutical & Chemical Bloomage Biotechnology Corporation Limited Bornsun Bioengineering Luoyang Huarong Anhui Xinnuobei Hefei Maikeluo Biological Engineering Hangzhou Viablife Biotech Guangxi Hanhe Biotech